Arkles Jeffrey S, Marchlinski Francis
Electrophysiology Section, Division of Cardiovascular Medicine, University of Pennsylvania, Philadelphia, PA, USA.
J Innov Card Rhythm Manag. 2019 Apr 15;10(4):3605-3610. doi: 10.19102/icrm.2019.100407. eCollection 2019 Apr.
The successful management of ventricular arrhythmias (VAs) in people with left ventricular assist devices (LVADs) is often complex. The need for and the role of defibrillator therapy is continually evolving in this group. VAs occur frequently and significantly impact the clinical course of patients with LVADs. The management of VAs begins prior to LVAD implantation and typically involves appropriate implantable cardioverter-defibrillator use and programming after the fact. Surgical ablation during LVAD implantation and supplementary catheter ablation performed as needed are attractive options for the management of VAs in this population. The performance of catheter ablation is generally safe and feasible after LVAD implantation with a team approach.
对于植入左心室辅助装置（LVAD）的患者，室性心律失常（VA）的成功管理往往很复杂。在这一群体中，除颤器治疗的必要性和作用也在不断演变。VA频繁发生，对LVAD患者的临床病程有重大影响。VA的管理在LVAD植入前就已开始，通常包括事后适当使用植入式心律转复除颤器并进行编程。LVAD植入期间的手术消融以及根据需要进行的补充导管消融是管理该人群VA的有吸引力的选择。采用团队协作方法，LVAD植入后进行导管消融通常是安全可行的。
